Lindsey Beus, NP-C | |
174 W Highway 287, Florence, AZ 85132 | |
(520) 868-5811 | |
(520) 868-1223 |
Full Name | Lindsey Beus |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Location | 174 W Highway 287, Florence, Arizona |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063036598 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 238745 (Arizona) | Secondary |
363L00000X | Nurse Practitioner | 238745 (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
Lindsey Beus, NP-C Po Box 10097, Casa Grande, AZ 85130-0020 Ph: (520) 836-3446 | Lindsey Beus, NP-C 174 W Highway 287, Florence, AZ 85132 Ph: (520) 868-5811 |
News Archive
A new treatment for prostate cancer called Provenge won a vote of confidence from a Medicare coverage advisory committee Wednesday, suggesting the federal program is likely to pay for the $93,000-per-patient medicine.
At the premier European forum on rheumatologic disorders, ImmunArray, maker of a breakthrough technology that provides unprecedented levels of accuracy in ruling out the presence of lupus through a simple blood test, announced today that it is launching its new SLE-key™ Rule Out test in selected U.S. markets on July 1, 2015.
For the third consecutive year (twelve consecutive calendar quarters), hospital users have rated Hitachi Medical Systems #1 MR vendor according to the Q1 2013 MD Buyline User Satisfaction Ratings Report.
InNexus Biotechnology Inc. announced today that the Company will embark on a business development initiative for DXL625™ (CD20), the Company's lead preclinical candidate for the prospective treatment of Non-Hodgkin's Lymphoma and/or Chronic Lymphocytic Leukemia.
A Lancaster PhD student is investigating the effects on older people's health of chronic exposure to low level carbon monoxide.
› Verified 4 days ago